AbCellera Biologics Inc. — Investor Relations & Filings
AbCellera Biologics Inc. is a clinical-stage biotechnology company that discovers and develops antibody-based therapeutics. The company operates a proprietary, full-stack technology platform that integrates biology, computation, and engineering to search and analyze natural immune systems for therapeutic antibodies. This engine is designed to accelerate the development of first-in-class and best-in-class medicines. AbCellera advances its own internal pipeline and also partners with other pharmaceutical and biotech companies to address challenging drug discovery problems. Its capabilities support programs involving complex targets such as transmembrane proteins, bispecifics, and antibody drug conjugates for conditions with high unmet medical need.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-06-05 | English | |
| 10-Q - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-05-11 | English | |
| ARS - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | |
| DEF 14A - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | |
| 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-03-02 | English | |
| 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-27 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 47982032 | 8-K | 2026-06-05 | English | ||
| 45000144 | 10-Q - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-05-11 | English | ||
| 38777908 | ARS - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | ||
| 38740788 | DEF 14A - AbCellera Biologics Inc. (0001703057) (Filer) | 2026-04-29 | English | ||
| 32896970 | 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-03-02 | English | ||
| 32896971 | 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-27 | English | ||
| 32896972 | 4 - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-27 | English | ||
| 32896981 | 10-K - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-24 | English | ||
| 32896975 | 8-K - ABCELLERA BIOLOGICS INC. (0001703057) (Filer) | 2026-02-24 | English | ||
| 13026668 | 8-K | 2026-01-14 | English | ||
| 13026671 | FORM 4 | 2026-01-05 | English | ||
| 13026672 | FORM 4 | 2026-01-05 | English | ||
| 13026679 | FORM 4 | 2026-01-05 | English | ||
| 13026674 | FORM 4 | 2026-01-05 | English | ||
|
2025
1 filing
| |||||
| 13026673 | FORM 4 | 2025-12-19 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abbott Laboratories (Pakistan) Limited
Manufactures and markets diverse healthcare products: pharm…
|
ABOT | PK | Manufacturing |
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
AbCellera Biologics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31942/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31942 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31942 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31942 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31942}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AbCellera Biologics Inc. (id: 31942)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.